| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Oruka Therapeutics, Inc.'s insiders have reduced their positions by a net 223,895 shares worth roughly $21.3M. In the past 30 days, 0 insiders bought and 4 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 4 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), ORKA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 931.9K | $77.72M | -25,000 | |
| COO | 235.5K | $22.54M | - | |
| 10% | 94.5K | - | - | |
| Dir | 38.7K | $2.72M | - | |
| Other | 35.9K | $2.65M | -7,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Goncalves Joana89 | Chief Medical Officer | Sale+OE | 7,000 | $74.81 | $523,647.72 | -18.1% | |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sale+OE | 9,999 | $80.60 | $805,888.87 | -41.3% | |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sale+OE | 25,000 | $83.62 | $2,090,593.27 | -2.6% | |
| Sep 21, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 533 | $95.75 | $51,034.75 | -3.6% | |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | Sale+OE | 10,000 | $93.64 | $936,417.48 | -25.0% | |
| Sep 15, 2026 | Goncalves Joana89 | Chief Medical Officer | Sale+OE | 7,947 | $92.38 | $734,144.91 | -20.0% | |
| Sep 15, 2026 | Klein Lawrence Otto | Chief Executive Officer | Sell | 2,452 | $95.71 | $234,680.92 | -0.3% | |
| Sep 15, 2026 | Quinlan Paul T | General Counsel | Sell | 1,039 | $95.71 | $99,442.69 | -3.3% | |
| Sep 15, 2026 | Sandler Laura Lee | Chief Operating Officer | Sell | 906 | $95.71 | $86,713.26 | -0.4% | |
| Sep 15, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sale+OE | 10,019 | $92.43 | $926,010.10 | -40.4% |